Tuesday, November 29, 2016

BRIEF-Novan reports statistically significant phase 2 clinical trial results for sb206

* Novan announces statistically significant phase 2 clinical

trial results for sb206

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)